Avoiding the uncertainties of dealing with the caveats of a <75 non-fully enrolled trial is a blessing. Having a few more seems even better.

Does anyone know the other types of therapy those in the trial may be using which could possibly complicate/convoluting the results. I am assuming some may be on Remdesivir? Wondering if the recent relaxation of trial enrollment criteria may have allowed more simultaneous treatments?

Thanks.